All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

PLx Pharma Inc. revenue reports

PLx Pharma Inc. financial reports, PLx Pharma Inc. annual revenue in 2024. When does PLx Pharma Inc. report revenue?
Add to widgets
Added to widgets

PLx Pharma Inc. total revenue, net income and dynamics of changes in US dollar today

Net revenue PLx Pharma Inc. is now 0 $. Information about net revenue is taken from open sources. The dynamics of net income of PLx Pharma Inc. has changed by -3 559 227 $ in recent years. Here are the main financial indicators of PLx Pharma Inc.. PLx Pharma Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Information on PLx Pharma Inc. net income on the chart on this page is drawn in blue bars. The value of PLx Pharma Inc. assets on the online chart is displayed in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 0 $ -100 % ↓ -11 540 511 $ -
31/12/2020 0 $ -100 % ↓ -7 981 284 $ -370.8858 % ↓
30/09/2020 0 $ -100 % ↓ -3 126 492 $ -283.51 % ↓
30/06/2020 27 907 $ -84.742 % ↓ -5 598 964 $ -
30/09/2019 41 106 $ - 1 703 722 $ -
30/06/2019 182 905 $ - -9 347 296 $ -
31/03/2019 317 560 $ - -10 858 751 $ -
31/12/2018 287 662 $ - 2 946 365 $ -
30/09/2018 216 530 $ - -3 425 073 $ -
30/06/2018 167 459 $ - -3 603 404 $ -
Show:
to

PLx Pharma Inc. financial report charts

The dates of the latest financial statements of PLx Pharma Inc.: 30/06/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of PLx Pharma Inc. is available online for such a date - 31/03/2021. Operating income PLx Pharma Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income PLx Pharma Inc. is -3 595 832 $

PLx Pharma Inc. quarterly report dates

Net income PLx Pharma Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income PLx Pharma Inc. is -11 540 511 $ Current assets PLx Pharma Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets PLx Pharma Inc. is 84 867 400 $ Total assets PLx Pharma Inc. refers to the total amount of assets owned by a person or entity. Total assets PLx Pharma Inc. is 88 320 915 $

Current cash PLx Pharma Inc. - the sum of all of the cash a company has on the date of report. Current cash PLx Pharma Inc. is 84 423 464 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
- - - 27 907 $ 41 106 $ 182 905 $ 317 560 $ 287 662 $ 216 530 $ 167 459 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
- - - - - - - - - -
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
- - - 27 907 $ 41 106 $ 182 905 $ 317 560 $ 287 662 $ 216 530 $ 167 459 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 41 106 $ 182 905 $ 317 560 $ 287 662 $ 216 530 $ 167 459 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-3 595 832 $ -3 691 993 $ -3 188 339 $ -3 574 138 $ -3 676 237 $ -3 849 179 $ -2 919 304 $ -2 523 432 $ -2 802 773 $ -2 397 373 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-11 540 511 $ -7 981 284 $ -3 126 492 $ -5 598 964 $ 1 703 722 $ -9 347 296 $ -10 858 751 $ 2 946 365 $ -3 425 073 $ -3 603 404 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
959 503 $ 1 222 877 $ 1 207 302 $ 1 394 881 $ 1 214 029 $ 1 598 884 $ 992 704 $ 890 239 $ 1 219 144 $ 734 246 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
3 595 832 $ 3 691 993 $ 3 188 339 $ 3 602 045 $ 3 717 343 $ 4 032 084 $ 3 236 864 $ 2 811 094 $ 3 019 303 $ 2 564 832 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
84 867 400 $ 22 985 501 $ 9 617 706 $ 13 764 123 $ 18 759 850 $ 21 716 917 $ 24 772 824 $ 14 865 410 $ 17 139 589 $ 19 217 021 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
88 320 915 $ 26 616 599 $ 13 350 837 $ 17 777 017 $ 22 986 740 $ 25 784 787 $ 28 891 737 $ 18 388 376 $ 20 718 294 $ 22 862 351 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
84 423 464 $ 22 448 651 $ 9 086 525 $ 13 257 204 $ 18 509 487 $ 21 256 643 $ 24 318 786 $ 14 250 267 $ 16 537 259 $ 17 924 709 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 6 173 884 $ 6 154 557 $ 5 099 325 $ 4 732 660 $ 3 540 837 $ 2 101 071 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 18 792 893 $ 25 034 324 $ 19 684 103 $ 11 944 083 $ 17 319 151 $ 16 308 171 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 81.76 % 97.09 % 68.13 % 64.95 % 83.59 % 71.33 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
44 660 956 $ -10 931 855 $ -19 720 453 $ -16 380 349 $ -10 208 820 $ -13 341 068 $ -4 453 944 $ 6 444 293 $ 3 399 143 $ 6 554 180 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -3 155 972 $ -2 592 986 $ -3 273 668 $ -2 286 992 $ -1 398 308 $ -2 095 041 $

Last revenue report of PLx Pharma Inc. was 31/03/2021. According to last financial report total revenue in PLx Pharma Inc. was 0 US dollar and changed by -100% since last year. Net income in PLx Pharma Inc. was -11 540 511 $ in last quartal, net income changes to -370.8858%.

PLx Pharma Inc. stocks data

PLx Pharma Inc. financials